ImmuneOncia Announces Positive Phase 1a Results of CD47 Monoclonal Antibody IMC-002 in Solid Tumors at ESMO 2023

04/11/2023 15:01:35
anti-spam
0 / 300

106 West 32nd Street, New York, NY 10001 | Copyright ©Tech Seoul All Rights Reserved